logo
Plus   Neg
Share
Email

Allergan: FDA Approves BOTOX For Pediatric Patients With Upper Limb Spasticity

Allergan plc (AGN) announced U.S. FDA approval of the company's sBLA for BOTOX for the treatment of pediatric patients with upper limb spasticity. BOTOX is the First Neurotoxin treatment approved to treat patients of, 2 to 17 years of age, for the therapeutic Indication. The approval was based on data from two Phase 3 studies evaluating BOTOX in over 200 pediatric patients.

The company's additional sBLA for the use of BOTOX to treat pediatric patients with lower limb spasticity, is currently under FDA review, and a decision is expected in the fourth quarter.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
While reporting financial results for the second quarter, Johnson & Johnson (JNJ) on Tuesday maintained its adjusted earnings forecast for the full year 2019, while raising sales outlook. For fiscal 2019, the company maintained its outlook for adjusted earnings in the range of $8.53 to $8.63 per share.... Canada's new regulations that provide extra protection for airline passengers will kick in Monday, July 15. The new rules from the Canada Transportation Agency, which has received severe backlash from industry and consumer advocates, requires airlines to compensate passengers up to $2,400 if they... California-based Fieldsource Food Systems Inc. has recalled about 13,000 pounds of diced beef and chicken products due to misbranding and undeclared allergens. The company says the product contain wheat, a known allergen, but is not declared on the product label. The uncooked, marinated, diced beef...
Follow RTT